Clene (CLNN) Capital Leases (2019 - 2023)
Clene (CLNN) posted Capital Leases of $3000.0 for Q1 2023, down 91.18% on a QoQ basis from $34000.0 in Q4 2022, and down 95.83% year-over-year from $72000.0 in Q1 2022.
Analysis
Clene (CLNN) Capital Leases (2019 - 2023) Analysis & Trends
Clene has reported Capital Leases for 5 years, with the latest figure at $3000.0 in Q1 2023.
- On a quarterly basis, Capital Leases fell 95.83% year-over-year to $3000.0 in Q1 2023; TTM through Mar 2023 was $3000.0, a 95.83% decrease from a year earlier, with the FY2022 full-year figure at $34000.0, down 64.95% from the prior year.
- Capital Leases was $3000.0 for Q1 2023 at Clene, down from $34000.0 in the prior quarter.
- The five-year high for Capital Leases was $389000.0 in Q4 2019, with the low at $3000.0 in Q1 2023.
- Average Capital Leases over 5 years is $126090.9, with a median of $97000.0 recorded in 2021.
- The sharpest annual moves came in 2020 and 2023: Capital Leases plunged 47.3% in 2020, then sank 95.83% in 2023.
- Over 5 years, Capital Leases stood at $389000.0 in 2019, then slumped by 47.3% to $205000.0 in 2020, then sank by 52.68% to $97000.0 in 2021, then tumbled by 64.95% to $34000.0 in 2022, then sank by 91.18% to $3000.0 in 2023.
- The last three Capital Leases figures came in at $3000.0 (Q1 2023), $34000.0 (Q4 2022), and $45000.0 (Q3 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 34,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Jun 30, 2022 | 55,000.00 |
| Mar 31, 2022 | 72,000.00 |
| Dec 31, 2021 | 97,000.00 |
| Sep 30, 2021 | 125,000.00 |
| Jun 30, 2021 | 152,000.00 |
| Mar 31, 2021 | 210,000.00 |
| Dec 31, 2020 | 205,000.00 |
| Dec 31, 2019 | 389,000.00 |